Imunon Statistics
Total Valuation
Imunon has a market cap or net worth of $10.69 million. The enterprise value is $2.67 million.
Important Dates
The next estimated earnings date is Monday, May 11, 2026, before market open.
| Earnings Date | May 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Imunon has 3.40 million shares outstanding. The number of shares has increased by 140.62% in one year.
| Current Share Class | 3.40M |
| Shares Outstanding | 3.40M |
| Shares Change (YoY) | +140.62% |
| Shares Change (QoQ) | -0.66% |
| Owned by Insiders (%) | 0.99% |
| Owned by Institutions (%) | 6.57% |
| Float | 3.02M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.33 |
| P/TBV Ratio | 1.48 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.32, with a Debt / Equity ratio of 0.14.
| Current Ratio | 2.32 |
| Quick Ratio | 1.90 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -256.41% and return on invested capital (ROIC) is -136.13%.
| Return on Equity (ROE) | -256.41% |
| Return on Assets (ROA) | -83.22% |
| Return on Invested Capital (ROIC) | -136.13% |
| Return on Capital Employed (ROCE) | -191.17% |
| Weighted Average Cost of Capital (WACC) | 14.52% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$579,800 |
| Employee Count | 25 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -75.25% in the last 52 weeks. The beta is 2.12, so Imunon's price volatility has been higher than the market average.
| Beta (5Y) | 2.12 |
| 52-Week Price Change | -75.25% |
| 50-Day Moving Average | 3.17 |
| 200-Day Moving Average | 5.01 |
| Relative Strength Index (RSI) | 52.37 |
| Average Volume (20 Days) | 208,822 |
Short Selling Information
The latest short interest is 208,865, so 6.14% of the outstanding shares have been sold short.
| Short Interest | 208,865 |
| Short Previous Month | 215,039 |
| Short % of Shares Out | 6.14% |
| Short % of Float | 6.92% |
| Short Ratio (days to cover) | 10.83 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -14.65M |
| Pretax Income | -14.50M |
| Net Income | -14.50M |
| EBITDA | -14.36M |
| EBIT | -14.65M |
| Earnings Per Share (EPS) | -$6.83 |
Full Income StatementBalance Sheet
The company has $8.78 million in cash and $1.01 million in debt, with a net cash position of $7.77 million or $2.29 per share.
| Cash & Cash Equivalents | 8.78M |
| Total Debt | 1.01M |
| Net Cash | 7.77M |
| Net Cash Per Share | $2.29 |
| Equity (Book Value) | 7.06M |
| Book Value Per Share | 2.41 |
| Working Capital | 6.10M |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 289,107 |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
